Automatic Website Traffic Generator


US   France   Germany   Spain   Netherlands  

Synthetic THC drug Syndros poised for Schedule II classification | Latest News

DEA awards Schedule II classification to synthetic THC drug

On March 23, 2017, the DEA announced it has scheduled the newly approved synthetic THC-containing drug, Syndros, as a Class II substance ... that the DEA would lessen the classification of cannabis to a Schedule II substance, which are defined as drugs ... read more

FDA To Evaluate Marijuana For Potential Reclassification As Less Dangerous Drug

The Food and Drug Administration is reviewing the medical evidence surrounding the safety and effectiveness of marijuana, a process that could lead to the agency downgrading the drug's current status as a Schedule I drug, the most dangerous classification. read more

Synthetic Cannabinoid Pharmaceuticals Spotlight

Due to the DEA's drug classification ... Cesamet is a Schedule II drug. Syndros from Insys Therapeutics (NASDAQ:INSY) Approved this year, according to reports, Syndros is an oral solution of dronabinol (synthetic THC), and is FDA approved for anorexia ... read more

Marijuana's Biggest Enemy Is Not Jeff Sessions–It's Big Pharma

The company's latest drug, Syndros, was a synthetic version ... preliminary approval and a Schedule II classification (meaning it has recognized medical value but is still considered dangerous) from the DEA late last week. Marijuana, of course, remains ... read more

Is marijuana close to being legalized?

The DEA has consistently refused to reclassify marijuana. It did move Marinol, synthetic THC capsules, from Schedule II to Schedule ... cannabis-based drugs held promise for treating pain, nausea from chemotherapy, and the “wasting syndrome” from ... read more

Southern California biotech companies see potential in marijuana

The 40-year-old said cannabis ... classification of individual cannabis-related pharmaceuticals if they’re approved for patient use. Marinol, for example, is a Schedule III drug, akin to Tylenol with codeine. And a similar pill, Cesamet, is Schedule II ... read more

Powerful Court Quietly Takes Marijuana Case That Could Shatter Federal Prohibition Laws

The DEA has consistently refused to reclassify marijuana. It did move Marinol, synthetic THC capsules, from Schedule II to Schedule ... cannabis-based drugs held promise for treating pain, nausea from chemotherapy, and the “wasting syndrome” from ... read more

Marijuana for Pediatric Seizures?

The Utah center also hopes to participate in an upcoming phase 3 trial of the same drug in pediatric patients with Dravet syndrome and Lennox ... colleagues are advocating that marijuana to be reclassified as a Schedule II or below substance, or even ... read more

Living With Medical Marijuana

I mention the detail because Vines is an AIDS patient afflicted with wasting syndrome; for someone in his situation ... a D.E.A. administrative law judge held hearings on rescheduling marijuana as a Schedule II drug so doctors could prescribe it, he ... read more
Popular RSS Feeds: need for speed cast snhu one card seo services amapola flower ers multicast bobs four cycle psychics pre approval mortgage scottish tablet recipe what is dpi tree texture plumbing io psychology tuition assistance navy sdn forums the west australian funeral notices home & contents insurance we day toronto running in the usa he in spanish day middle school


Buy AutoTrafficRSS script now for $27 only!

We will send the script to your PayPal email within few hours,
Please add FullContentRSS@gmail.com to your email contact.



Auto Traffic generator Powered by. Full RSS Feed | Article Generator | Contact Us